Bank MNC Internasional Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank MNC Internasional Tbk trades at Rp50 (market cap 2.2T, 74K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 164.65B, 214.9K 24h volume). The key difference: Bank MNC Internasional Tbk is far larger — about 13.4× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (214.9K versus 74K). Which is the better fit depends on your goals.
| BABP | OBAT | |
|---|---|---|
Market Cap | 2.2T | 164.65B |
Volume | 74K | 214.9K |
Lot | 740 | 2.15K |
Turnover | 3.7M | 51.97M |
Average Price | 50 | 241.85 |
Value | 3.7M | 51.97M |
Indicative Equilibrium Price | 50 | 240 |
Indicative Equilibrium Volume | 1 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank MNC Internasional Tbk formerly PT Bank ICB Bumiputera Tbk ( Bank) was established in Indonesia under the name PT Bank Bumiputera Indonesia under Notarial Deed No. 49 dated July 31, 1989 of Mrs. Sri Rahayu, S.H., notary in Jakarta.
Read more on BABP →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →